↓ Skip to main content

Dove Medical Press

Article Metrics

Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
194 Mendeley
Title
Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options
Published in
Therapeutics and Clinical Risk Management, April 2015
DOI 10.2147/tcrm.s67387
Pubmed ID
Authors

Susan Cornell

Abstract

Diabetes is a complex and progressive disease that has a major societal and economic impact. The most common form of diabetes, type 2 diabetes mellitus (T2DM), is a multifactorial disease, the pathophysiology of which involves not only the pancreas but also the liver, skeletal muscle, adipose tissue, gastrointestinal tract, brain, and kidney. Novel therapies with mechanisms of action that are different from most existing drugs are emerging. One such class consists of compounds that inhibit renal sodium-glucose cotransporter 2, which is responsible for the bulk of glucose reabsorption by the kidneys. This new class of compounds improves glycemic control independently of insulin and promotes weight reduction, providing an additional tool to treat patients with T2DM. This review discusses the underlying pathophysiology of T2DM, clinical guidelines, and available and emerging treatment options, with particular emphasis on sodium-glucose cotransporter 2 inhibitors.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
South Africa 1 <1%
France 1 <1%
Mexico 1 <1%
Russia 1 <1%
Spain 1 <1%
Unknown 187 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 46 24%
Student > Master 41 21%
Student > Ph. D. Student 22 11%
Student > Postgraduate 12 6%
Researcher 12 6%
Other 25 13%
Unknown 36 19%
Readers by discipline Count As %
Medicine and Dentistry 61 31%
Agricultural and Biological Sciences 29 15%
Biochemistry, Genetics and Molecular Biology 24 12%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Nursing and Health Professions 9 5%
Other 22 11%
Unknown 39 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2017.
All research outputs
#9,426,816
of 16,980,059 outputs
Outputs from Therapeutics and Clinical Risk Management
#482
of 1,092 outputs
Outputs of similar age
#125,064
of 277,745 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 21 outputs
Altmetric has tracked 16,980,059 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,092 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,745 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.